ArticleChemMedChem2026
Co(II), Cu(II), and Ni(II) Coordination Complexes: Synthesis, Characterization, Experimental, and Computational Study on Potential Antiplasmodial Activity.
Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
In this work, the synthesis and structural characterization of coordination complexes C1 (Co-Cl), C2 (Cu-Cl), C3 (Co-Br), and C4 (Ni-Cl) with the ligand 2-(tert-butoxy)-6-(1H-imidazol-1-yl)pyridine (L) was carried out. The X-ray diffraction reveals the presence of four equatorial L and two axial halogens as coligands. The synthesized complexes crystallize in a P-1 space group. Topological analysis using ToposPro assigned the discrete 1,6M7-1 topology, in which ZA1 and ZA2 represent nonequivalent supramolecular ligand contacts, while the suffix -1 denotes the first nonisomorphic net not included in the RCSR database. The complexes were evaluated against Plasmodium falciparum, showing the high influence of the metal coordination in the modulation of the antiplasmodial activity relative to the free ligand, particularly against the resistant phenotype. All evaluated complexes retained inhibitory effects against both chloroquine-sensitive and chloroquine-resistant P. falciparum strains. Among the series, C3 and C4 emerged as the most promising candidates due to their favorable balance between antiplasmodial activity, selectivity, and low hemolytic profile. Computational analyses further revealed that modulation of the electronic properties, chemical softness, and lipophilic profiles of the complexes may contribute to their distinct biological behavior, while molecular docking suggested plausible interactions with parasite-associated enzymatic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.